At what pace is the genome sequencing market growing, and what is its estimated value?
The genome sequencing market size has grown rapidly in recent years. It will grow from $9.89 $ billion in 2024 to $11.78 $ billion in 2025 at a compound annual growth rate (CAGR) of 19.1%. The growth in the historic period can be attributed to increasing research funding, growing awareness of personalized medicine, rise in genomic data, expansion of clinical applications, and increasing demand for biomarker discovery.
The genome sequencing market size is expected to see rapid growth in the next few years. It will grow to $23.63 $ billion in 2029 at a compound annual growth rate (CAGR) of 19.0%. The growth in the forecast period can be attributed to growth in genomic research, an increase in the prevalence of genetic disorders, increasing cancer occurrence, integration with other omics, and rising public awareness and acceptance. Major trends in the forecast period include advancements in next-generation sequencing (NGS) technologies, integration with artificial intelligence (AI) and machine learning (ML), expansion of direct-to-consumer (DTC) genetic testing, development of portable sequencing devices, and the rise of personalized medicine.
Get Your Free Sample of The Global Genome Sequencing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19484&type=smp
What are the top drivers to the rising demand in the genome sequencing market?
The increasing occurrence of cancer is expected to propel the growth of the genome sequencing market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells, which can lead to death if not controlled. The occurrence of cancer is rising due to several factors, including the aging population, lifestyle factors, environmental exposures, and genetic predispositions. Genome sequencing helps identify genetic mutations and predispositions to cancer, enabling early detection and personalized treatment plans. It reveals inherited cancer risks and assists in tracking the development of cancerous cells. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, new cancer cases are projected to reach over 35 million by 2050, representing a 77% increase compared to 20 million cases in 2022. Therefore, the increasing occurrence of cancer is driving the growth of the genome sequencing market.
How is the genome sequencing market segmented?
The genome sequencingmarket covered in this report is segmented –
1) By Product: Consumables, Systems And Software, Services
2) By Technology: Polymerase Chain Reaction (PCR), Sequencing, Microarray, Nucleic Acid Extraction, Purification, Other Technologies
3) By Applications: Diagnostics, Drug Discovery, Precision Medicine, Environmental Genomics, Research, Other Applications
4) By End-User: Hospitals And Clinics, Biotechnology And Pharmaceutical Companies, Contract Research Organizations (CROs), Government, Research Centers, Academic And Government Institutes, Other End-Users
Subsegments:
1) By Consumables: Reagents And Kits, Sequencing Chips And Plates, Sample Preparation Products, Library Preparation Kits, DNA And RNA Extraction Kits
2) By Systems And Software: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Bioinformatics Software And Analysis Tools, Data Management And Storage Solutions, Laboratory Information Management Systems (LIMS)
3) By Services: Sequencing Services, Bioinformatics Analysis Services, Consultation And Support Services, Custom Genome Sequencing Solutions, Sample Collection And Preparation Services.
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/genome-sequencing-global-market-report
Who are the top competitors in the genome sequencing market?
Major companies operating in the genome sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton, Dickinson and Company, Eurofins Genomics, Agilent Technologies Inc., PerkinElmer, Illumina Inc., bioMérieux, Bio-Rad Laboratories Inc., QIAGEN N.V., 10x Genomics Inc., BGI Group, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., GENEWIZ Inc., LI-COR Inc., CENTOGENE N.V., Bioneer Corporation, Strand Life Sciences Pvt Ltd., Nebula Genomics
What significant trends should we anticipate in the genome sequencing market over the forecast period?
Major companies operating in the genome sequencing market are focused on developing advanced solutions, such as next-generation sequencing (NGS)-based assays, to enhance the accuracy of genetic analysis and enable personalized medicine approaches. Next-generation sequencing (NGS)-based assays refer to advanced genomic technologies that will allow rapid and high-throughput sequencing of DNA or RNA to analyze genetic material. NGS allows for the simultaneous sequencing of millions of fragments of DNA or RNA, generating large volumes of data quickly and at a lower cost. For instance, in April 2023, Centogene N.V., a Germany-based provider of genetic diagnostics for rare diseases, launched CentoGenome, an enhanced Next Generation Sequencing (NGS)-based assay. It offers lifelong diagnostic support with proactive diagnosis confirmation and reclassification programs at no extra cost, ensuring continuous patient care and precise disease management. Utilizing a PCR-free approach, CentoGenome reduces bias and enhances sequencing quality, providing better coverage of challenging genomic regions and improving insights into coding, regulatory, and intronic areas. The platform features an automated bioinformatics pipeline and medical expert analysis, utilizing CENTOGENE’s extensive bio databank of data from about 700,000 patients in over 120 countries. This comprehensive dataset boosts the detection of disease-causing variants, including those associated with spinal muscular atrophy and Parkinson’s disease.
Which regional trends are influencing the genome sequencing market, and which area dominates the industry?
North America was the largest region in the genome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Genome Sequencing Market Report 2025 Offer?
The genome sequencing market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Genome sequencing is the process of determining the complete DNA sequence of an organism’s genome. It involves identifying the precise order of nucleotides (adenine, cytosine, guanine, and thymine) in the genome, which includes all of an organism’s genetic material. Genome sequencing provides comprehensive information about the genetic blueprint of an organism, enabling scientists to understand genetic variations, identify mutations, and study the relationships between genes and traits or diseases.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19484
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
